Introduction to Axonics Therapy
Axonics therapy, also known as sacral neuromodulation, is a treatment option for individuals suffering from urinary incontinence or overactive bladder. This innovative therapy involves the implantation of a small device that stimulates the sacral nerves, helping to regulate bladder function and alleviate symptoms.
The Axonics System is a FDA-approved, rechargeable device that provides long-term relief from urinary incontinence and overactive bladder. With its minimally invasive implantation procedure and adjustable stimulation settings, Axonics therapy has become a popular choice among patients seeking effective and convenient treatment.
Medicare Coverage for Axonics Therapy
Medicare coverage for Axonics therapy is available for eligible patients who meet specific criteria. To qualify, patients must have a confirmed diagnosis of urinary incontinence or overactive bladder and have tried other treatment options without success.
Medicare Part B typically covers the costs of the Axonics System, including the implantation procedure and follow-up care. However, patients may be responsible for copays, deductibles, and other out-of-pocket expenses, which can vary depending on their individual Medicare plan and coverage.
Costs and Criteria for Axonics Therapy
The costs of Axonics therapy can vary depending on the patient's location, insurance coverage, and other factors. On average, the total cost of the Axonics System, including implantation and follow-up care, can range from $15,000 to $25,000 or more.
To be eligible for Medicare coverage, patients must meet specific criteria, including a confirmed diagnosis, failed conservative treatments, and a thorough evaluation by a qualified healthcare provider. Patients must also be willing and able to undergo the implantation procedure and follow-up care.
Eligibility and Requirements for Medicare Coverage
To be eligible for Medicare coverage of Axonics therapy, patients must meet specific requirements, including a confirmed diagnosis of urinary incontinence or overactive bladder, failed conservative treatments, and a thorough evaluation by a qualified healthcare provider.
Additionally, patients must be willing and able to undergo the implantation procedure and follow-up care, and must have a Medicare plan that covers the costs of the Axonics System and related services.
Conclusion and Next Steps
Axonics therapy is a highly effective treatment option for individuals suffering from urinary incontinence or overactive bladder, and Medicare coverage is available for eligible patients who meet specific criteria.
If you are considering Axonics therapy and want to learn more about Medicare coverage and costs, consult with a qualified healthcare provider or contact a Medicare representative to discuss your options and determine the best course of treatment for your specific needs.
Frequently Asked Questions
What is Axonics therapy and how does it work?
Axonics therapy is a treatment for urinary incontinence and overactive bladder that involves implanting a small device to stimulate the sacral nerves and regulate bladder function.
Is Axonics therapy covered by Medicare?
Yes, Medicare covers Axonics therapy for eligible patients who meet specific criteria, including a confirmed diagnosis and failed conservative treatments.
How much does Axonics therapy cost?
The cost of Axonics therapy can range from $15,000 to $25,000 or more, depending on the patient's location, insurance coverage, and other factors.
What are the criteria for Medicare coverage of Axonics therapy?
To be eligible for Medicare coverage, patients must have a confirmed diagnosis, failed conservative treatments, and meet specific requirements, including a thorough evaluation by a qualified healthcare provider.
Can I get Axonics therapy if I have a Medicare Advantage plan?
Yes, Medicare Advantage plans typically cover Axonics therapy, but patients should check with their plan provider to confirm coverage and costs.
How long does the Axonics System last and what is the maintenance required?
The Axonics System is a rechargeable device that can last for several years, and patients typically need to recharge the device every 1-2 weeks, depending on the stimulation settings and usage.